Found: 34
Select item for more details and to access through your institution.
Robust humoral and cellular recall responses to AZD1222 attenuate breakthrough SARS-CoV-2 infection compared to unvaccinated.
- Published in:
- Frontiers in Immunology, 2023, v. 13, p. 1, doi. 10.3389/fimmu.2022.1062067
- By:
- Publication type:
- Article
Association of Rapid Molecular Testing With Duration of Respiratory Isolation for Patients With Possible Tuberculosis in a US Hospital.
- Published in:
- 2018
- By:
- Publication type:
- journal article
IL-6 Receptor Antagonist Therapy for Patients Hospitalized for COVID-19: Who, When, and How?
- Published in:
- 2021
- By:
- Publication type:
- editorial
Doxycycline as Postsexual Exposure Prophylaxis: Use, Acceptability, and Associated Sexual Health Behaviors Among a Multi-Site Sample of Clinical Trial Participants.
- Published in:
- AIDS Patient Care & STDs, 2024, v. 38, n. 4, p. 155, doi. 10.1089/apc.2023.0289
- By:
- Publication type:
- Article
Reinfection and Risk Behaviors After Treatment of Hepatitis C Virus Infection in Persons Receiving Opioid Agonist Therapy : A Cohort Study.
- Published in:
- Annals of Internal Medicine, 2022, v. 175, n. 9, p. 1221, doi. 10.7326/M21-4119
- By:
- Publication type:
- Article
Immunogenicity of the BA.1 and BA.4/BA.5 Severe Acute Respiratory Syndrome Coronavirus 2 Bivalent Boosts: Preliminary Results From the COVAIL Randomized Clinical Trial.
- Published in:
- Clinical Infectious Diseases, 2023, v. 77, n. 4, p. 560, doi. 10.1093/cid/ciad209
- By:
- Publication type:
- Article
Switching to Bictegravir, Emtricitabine, and Tenofovir Alafenamide in Virologically Suppressed Adults With Human Immunodeficiency Virus.
- Published in:
- Clinical Infectious Diseases, 2021, v. 73, n. 2, p. e485, doi. 10.1093/cid/ciaa988
- By:
- Publication type:
- Article
Doxycycline Prophylaxis for Bacterial Sexually Transmitted Infections.
- Published in:
- Clinical Infectious Diseases, 2020, v. 70, n. 6, p. 1247, doi. 10.1093/cid/ciz866
- By:
- Publication type:
- Article
Immunogenicity of a 2-Dose Regimen of Moderna mRNA Beta/Omicron BA.1 Bivalent Variant Vaccine Boost in a Randomized Clinical Trial.
- Published in:
- Journal of Infectious Diseases, 2023, v. 228, n. 12, p. 1662, doi. 10.1093/infdis/jiad323
- By:
- Publication type:
- Article
Tuberculosis Drug Development.
- Published in:
- American Journal of Respiratory & Critical Care Medicine, 2011, v. 184, n. 10, p. 1107, doi. 10.1164/rccm.201106-0995PP
- By:
- Publication type:
- Article
Hepatitis C Elimination During a Global Pandemic: A Case Study of Resilience in Action.
- Published in:
- Public Health Reports, 2022, v. 137, n. 4, p. 649, doi. 10.1177/00333549221083741
- By:
- Publication type:
- Article
Impact of Larger Sputum Volume on Xpert® MTB/RIF Assay Detection of Mycobacterium tuberculosis in Smear-Negative Individuals with Suspected Tuberculosis.
- Published in:
- Journal of Clinical Medicine, 2017, v. 6, n. 8, p. 78, doi. 10.3390/jcm6080078
- By:
- Publication type:
- Article
Characteristics of High-Titer Convalescent Plasma and Antibody Dynamics After Administration in Patients With Severe Coronavirus Disease 2019.
- Published in:
- Open Forum Infectious Diseases, 2021, v. 8, n. 8, p. 1, doi. 10.1093/ofid/ofab385
- By:
- Publication type:
- Article
Safety and Efficacy of Ombitasvir, Paritaprevir With Ritonavir ± Dasabuvir With or Without Ribavirin in Patients With Human Immunodeficiency Virus-1 and Hepatitis C Virus Genotype 1 or Genotype 4 Coinfection: TURQUOISE-I Part 2.
- Published in:
- Open Forum Infectious Diseases, 2017, v. 4, n. 3, p. 1, doi. 10.1093/ofid/ofx154
- By:
- Publication type:
- Article
DOXYPEP & ANTIMICROBIAL RESISTANCE IN N. GONORRHOEAE, COMMENSAL NEISSERIA & S. AUREUS.
- Published in:
- Topics in Antiviral Medicine, 2023, v. 31, n. 2, p. 49
- By:
- Publication type:
- Article
CROI 2021: Viral Hepatitis and Other Forms of Liver Injury Impacting People with HIV.
- Published in:
- Topics in Antiviral Medicine, 2021, v. 29, n. 3, p. 379
- By:
- Publication type:
- Article
CROI 2019: Highlights of Viral Hepatitis.
- Published in:
- Topics in Antiviral Medicine, 2019, v. 27, n. 1, p. 41
- By:
- Publication type:
- Article
CROI 2018: Highlights of Viral Hepatitis.
- Published in:
- Topics in Antiviral Medicine, 2018, v. 26, n. 1, p. 30
- By:
- Publication type:
- Article
Understanding Hepatitis C Virus Drug Resistance: Clinical Implications for Current and Future Regimens.
- Published in:
- Topics in Antiviral Medicine, 2017, v. 25, n. 3, p. 103
- By:
- Publication type:
- Article
CROI 2017: Highlights of Advances in Viral Hepatitis and Liver Fibrosis.
- Published in:
- Topics in Antiviral Medicine, 2017, v. 25, n. 2, p. 84
- By:
- Publication type:
- Article
CROI 2016: Viral Hepatitis and Liver Fibrosis.
- Published in:
- Topics in Antiviral Medicine, 2016, v. 24, n. 1, p. 47
- By:
- Publication type:
- Article
CROI 2015: Highlights of Viral Hepatitis Therapy.
- Published in:
- Topics in Antiviral Medicine, 2015, v. 23, n. 1, p. 66
- By:
- Publication type:
- Article
CROI 2014: Viral Hepatitis and Complications of HIV Disease and Antiretroviral Therapy.
- Published in:
- Topics in Antiviral Medicine, 2014, v. 22, n. 2, p. 602
- By:
- Publication type:
- Article
Sofosbuvir and Ribavirin for Hepatitis C in Patients With HIV Coinfection.
- Published in:
- JAMA: Journal of the American Medical Association, 2014, v. 312, n. 4, p. 353, doi. 10.1001/jama.2014.7734
- By:
- Publication type:
- Article
Efficacy and Safety of Glecaprevir/Pibrentasvir in Patients Coinfected With Hepatitis C Virus and Human Immunodeficiency Virus Type 1: The EXPEDITION-2 Study.
- Published in:
- Clinical Infectious Diseases, 2018, v. 67, n. 7, p. 1010, doi. 10.1093/cid/ciy220
- By:
- Publication type:
- Article
Combined Effect of CYP2B6 and NAT2 Genotype on Plasma Efavirenz Exposure During Rifampin-based Antituberculosis Therapy in the STRIDE Study.
- Published in:
- Clinical Infectious Diseases, 2016, v. 62, n. 12, p. 1860, doi. 10.1093/cid/civ155
- By:
- Publication type:
- Article
Evaluation of Xpert MTB/RIF Versus AFB Smear and Culture to Identify Pulmonary Tuberculosis in Patients With Suspected Tuberculosis From Low and Higher Prevalence Settings.
- Published in:
- Clinical Infectious Diseases, 2016, v. 62, n. 9, p. 1081, doi. 10.1093/cid/ciw035
- By:
- Publication type:
- Article
Combined Effect of CYP2B6 and NAT2 Genotype on Plasma Efavirenz Exposure During Rifampin-based Antituberculosis Therapy in the STRIDE Study.
- Published in:
- Clinical Infectious Diseases, 2015, v. 60, n. 12, p. 1860, doi. 10.1093/cid/civ155
- By:
- Publication type:
- Article
Relationship Between Weight, Efavirenz Exposure, and Virologic Suppression in HIV-Infected Patients on Rifampin-Based Tuberculosis Treatment in the AIDS Clinical Trials Group A5221 STRIDE Study.
- Published in:
- Clinical Infectious Diseases, 2013, v. 57, n. 4, p. 586
- By:
- Publication type:
- Article
Ledipasvir/sofosbuvir for treatment of hepatitis C virus in sofosbuvir‐experienced, NS5A treatment‐naïve patients: Findings from two randomized trials.
- Published in:
- Liver International, 2018, v. 38, n. 6, p. 1010, doi. 10.1111/liv.13616
- By:
- Publication type:
- Article
Role of a clinical pharmacist as part of a multidisciplinary care team in the treatment of HCV in patients living with HIV/HCV coinfection.
- Published in:
- Integrated Pharmacy Research & Practice, 2018, v. 10, p. 105, doi. 10.2147/IPRP.S169282
- By:
- Publication type:
- Article
A survey of tuberculosis infection control practices at the NIH/NIAID/DAIDS-supported clinical trial sites in low and middle income countries.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Optimizing Hydroxychloroquine Dosing for Patients With COVID‐19: An Integrative Modeling Approach for Effective Drug Repurposing.
- Published in:
- Clinical Pharmacology & Therapeutics, 2020, v. 108, n. 2, p. 253, doi. 10.1002/cpt.1856
- By:
- Publication type:
- Article
HCV treatment barriers among HIV/HCV co-infected patients in the US: a qualitative study to understand low uptake among marginalized populations in the DAA era.
- Published in:
- Journal of Public Health, 2019, v. 41, n. 4, p. e283, doi. 10.1093/pubmed/fdz045
- By:
- Publication type:
- Article